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SUPPLEMENTAL FIGURE LEGENDS 
Figure S1. Properties of Cul1•Cand1 complex assembly and disassembly (related to 
Figure 1).  
(A) kobs for Cand1 binding to Cul1. The change in donor fluorescence versus time was 
measured in a stopped-flow fluorimeter upon addition of varying concentrations of FlAsH∆H1Cand1 
to 50 nM Cul1AMC•Rbx1. Indicated concentrations are after 1:1 (v:v) mixing of the two solutions 
in the stopped-flow fluorimeter. Signal changes were fit to two phase exponential curves, and 
the fast-phase rates were used as kobs. These values are plotted against [Cand1] in Fig 1B. 
(B) kobs for Cand1 binding to Cul1 preassembled with Skp1•Skp2. Similar to Fig S1A, except 
100 nM Skp1•Skp2 was preincubated with 50 nM Cul1AMC. Signal changes were fit to two phase 
exponential curves, and the fast-phase rates were used as kobs. These values are plotted 
against [Cand1] in Fig 1C. 
(C) kobs for Cand1•Cul1 dissociation by Skp1•Skp2. The change in donor fluorescence versus 
time was measured in a stopped-flow fluorimeter upon addition of varying concentrations of 
Skp1•Skp2 to 10 nM FlAsH∆H1Cand1•Cul1AMC•Rbx1. Indicated concentrations are after 1:1 (v:v) 
mixing of the two solutions in the stopped-flow fluorimeter. Signal changes were fit to single 
exponential curves. These values are plotted against [Skp1•Skp2] in Fig 1E.  
(D) Replacing the first helix of Cand1 with the tetracysteine tag increased the koff of Cand1 from 
Cul1•Rbx1. Fluorescence emission at 445 nm (donor emission) was detected every 2 seconds 
after the addition of 10 x excess FlAsH∆H1Cand1 (acceptor protein) to Cul1AMC•Rbx1 pre-incubated 
with unlabeled Cand1 or ∆H1Cand1. FRET was observed following spontaneous dissociation of 
non-fluorescent Cand1 from Cul1AMC•Rbx1. Signal changes were fit to exponential curves with a 
fixed end point of 70% initial donor fluorescence. Cand1•Cul1AMC•Rbx1 was fit to a one phase 
curve. ∆H1Cand1•Cul1AMC•Rbx1 was fit to a two phase curve, with koff, slow similar to the koff of 
Cand1•Cul1AMC•Rbx1 and koff, fast about 20 times faster.  
(E) ∆H1Cand1•Cul1•Rbx1 is less stable than Cand1•Cul1•Rbx1. Skp1•Skp2, Cul1•GSTRbx1, 
Cand1 or ∆H1Cand1 at indicated concentrations were used in the GST pulldown (PD) assay. 
Relative level of recovered Cand1 is shown as Cand1:GSTRbx1 ratio. Based on this result and 
the known KD of Cul1•Skp1•Fbxw7, the KD of 
∆H1Cand1•Cul1 is simulated to be ~4.5 times 
higher than the KD of Cand1•Cul1. In this and other experiments employing recombinant Cul1, it 
migrates faster than expected because it is expressed by the ‘split-n-coexpress’ (split’n) method 
of Li et al (2005). 
(F) β-TrCP removes Cand1 from Cul1 when it is in complex with full length Skp1 but not Skp1 
with loop regions deleted. The change in donor fluorescence versus time was measured in a 
  
stopped-flow apparatus upon addition of 75 nM Skp1•β-TrCP or Skp1ΔΔ•β-TrCP to 25 nM 
FlAsH∆H1Cand1•Cul1AMC•Rbx1.  
(G) Deletion of β-hairpin in Cand1 or loop regions in Skp1 enables formation of a stable 
complex comprising Cul1, Skp1, and Cand1. In vitro pull-down assays containing the indicated 
proteins were performed to demonstrate the formation of stable complexes consisting of 
Cul1•Rbx1, Skp1 and GSTCand1 when Cand1 and/or Skp1 was mutated to delete structural 
elements that are predicted to clash in the Cand1•Cul1•Rbx1•Skp1 complex. The indicated 
proteins were mixed in equimolar amounts and bound to glutathione-4B resin. Proteins 
associated with the resin were fractionated by SDS-PAGE and detected by silver stain.  
 
Figure S2. Degradation defects in Cand1∆, Cand2∆, and Cand1/2 double knockout cells 
(related to Figure 2). Complex of Cand1•Cul1•Dcn1 (related to Figure 3).  
(A) Cand2•Cul1 complex was detected only when Cand1 was depleted. IP-WB analysis of 
Cand1•Cul1 and Cand2•Cul1 complexes in control (shControl) and Cand1 knock-down 
(shCand1) cells that are stably expressing the shRNA (Pierce et. al., 2013). Cells were treated 
with 1 µg/ml tetracycline for 1 hour 24 hours before collection to induce expression of FLAGCul1 
integrated at the FRT site (Flp-In system).  
(B) Strategy for construction of Cand1/2 knockout cell lines. A pair of chimeric single-guide 
RNAs (sgRNA) guiding CRISPR Cas9 (D10A) nickases were designed to target the first exon of 
the Cand1 or Cand2 gene for mutagenesis. A homologous recombination (HR) template 
containing a drug resistance gene plus a translational terminator and two 300-bp homology 
arms that were identical to the genomic sequences flanking the first exon is depicted. Primer 1 
and primer 2 were used to generate PCR products of the mutated genomic region for 
sequencing and confirming the complete inactivation of Cand1 and Cand2 genes. Note that 
primer 2 probed the region outside of the 300-bp HR region on the genomic DNA.  
(C) Confirmation of Cand1 and Cand2 single KO cell lines. WB analysis showing the loss of 
Cand1 or Cand2 proteins in the corresponding KO cell lines. * marks a non-specific band, which 
serves as a loading control.  
(D) Confirmation of Cand1/2 DKO cell lines. WB analysis showing the loss of Cand1 and Cand2 
proteins in four DKO cell lines. DKO13, 22, 36 are independent cell lines confirmed by 
sequencing results. The filter stained with Ponceau S prior to probing is shown as a loading 
control. These lines initially displayed slower growth than the wild type (WT) cells, but the 
growth rate gradually increased after a few passages and became similar to the WT cells by the 
time their genotypes were confirmed.  
  
(E) IκBα degradation is defective in DKO13 cells. WB analysis of IκBα levels in WT and DKO13 
cells at indicated time points after TNFα treatment. DKO13 shows an IκBα degradation defect 
similar to the DKO22 and DKO36 lines shown in Fig 2A.  
(F) Cand1 but not Cand2 is required for proper degradation of IκBα. WB analysis of IκBα 
degradation in response to TNFα treatment in WT, Cand1/2 DKO, Cand2 single knockout 
(Cand2 KO) and Cand1 KO cells. Half-lives of IκBα in this analysis are shown in the graph.  
(G) Inhibiting neddylation stabilizes IκBα in both WT and DKO cells and enables quantification 
of the rate of IκBα phosphorylation. WB analysis of IκBα degradation in response to TNFα 
treatment in WT and DKO cells pretreated with either 0.1% DMSO or 1 µM MLN4924 for 1 hr. 
Half-lives of IκBα in this analysis are shown in the graph.  
(H) Inhibiting neddylation strongly inhibits IκBα ubiquitination. Expression of 3xFLAGIkBα cDNA 
integrated at the FRT site was induced with tetracycline for 24 hours and then 3xFLAGIkBα was 
immunopreciptiated from cell lysate with anti-FLAG following pre-treatment of the cells with 
either 0.1% DMSO or 1 µM MLN4924 for 1 hr before 10-min TNFα treatment. IPs were 
evaluated by WB analysis with antibodies against pIκBα.   
(I) pIκBα binds β-TrCP with equal efficiency in WT and DKO cells. WT and DKO cells 
expressing tetracycline-induced 3xFLAGIκBα and treated with 1 µM MLN4924 for 1 hr to block 
pIκBα ubiquitination were lysed and subjected to IP with anti-FLAG followed by WB analysis 
with the indicated antibodies to evaluate interaction between pIκBα and β-TrCP. This is 
essentially the same as the experiment in Fig 2G, except that ubiquitination of pIκBα was 
suppressed by MLN4924, instead of by treating the IPs with deububiquitinating enzyme Usp2. 
MLN4924 or Usp2 were used to collapse all pIκBα species into a single band to facilitate 
quantification. 
(J) Cand1 forms a complex with Dcn1 and Ubc12 only in the presence of Cul1. Reciprocal pull-
down assays were set up as indicated. Each protein was included at 1 µM. Proteins adsorbed to 
the glutathione beads were fractionated by SDS-PAGE and stained by Coomassie blue or 
subjected to WB with the indicated antibodies.  
(K) Binding of Cand1 alters the conformation of the Dcn1 binding site on Cul1. The C-terminal 
domains of Cul1 from PDB files of “4P5O” and “1U6G” were aligned in PyMOL, and the front 
and back views of the aligned Cand1•Cul1•Dcn1 are shown. Cand1 is in magenta and Dcn1 is 
in blue; Cul1 in complex with Cand1 is in green, and Cul1 in complex with Dcn1 is in yellow.  
 
Figure S3. Cand1 and neddylation (related to Figure 3). Development of the 
computational model (related to Figure 4 and Method S1).  
  
(A) Confirmation of the estimated KD of 5 x 10
-8 M for Dcn1 binding to Cand1•Cul1•Rbx1. 
Assays were similar to Fig 3C but lower concentrations of Cul1, Cand1 and GSTDcn1 were used. 
Proteins adsorbed to the glutathione beads were fractionated by SDS-PAGE and stained by 
Coomassie blue or subjected to WB with the Cul1 antibody. Fold increase of Cul1 recovered 
from the pulldown assay calculated by the KD values (Predicted) and measured from the 
experiments (Actual) are shown.  
(B-C) Negative controls for Fig 3F. (B) A mixture of 0.2 µM Cul1FAM and 0.2 µM Cul1TAMRA with 
or without 0.2 µM Dcn1 was incubated with 0.1 µM each of Nedd8, Ubc12, and NAE for 
indicated time period. FAM and TAMRA signals were detected by a Typhoon scanner.  
(C) 5x Skp1•Skp2 and DKO lysate indicated in Fig 3E was replaced with 0.1 µM each of Nedd8, 
Ubc12, and NAE, and no FBP was added.  
(D) Neddylation promotes the formation of SCF during the exchange process. Cand1, Dcn1 and 
Cul1•GSTRbx1 were pre-incubated with glutathione beads and then mixed 1:1 (v:v) with protein 
solution containing Skp1•β-TrCP and Ubc12 or Ubc12~Nedd8. At indicated time points after 
mixing, beads were washed and eluted, and immobilized proteins were fractionated by SDS-
PAGE and detected by WB. Final concentrations of the protein components were the same as 
in Fig 3G.  
(E) Dcn1 stabilizes the Cand1•Cul1•Rbx1 complex in the presence of FBP. Pulldown analysis of 
recombinant Cand1 (1 µM) bound to recombinant Cul1•GSTRbx1 (0.5 µM) in the presence of 
Skp1•Skp2 (2 µM) and increasing concentrations of Dcn1 (0-20 µM). Protein samples were 
fractionated by SDS-PAGE and stained with Coomassie Blue. Normalized levels of Cand1 
recovered were calculated as the ratio of Cand1 to GSTRbx1. 
(F) WB estimation of IκBα phosphorylation rate. WT cells were treated with 1 µM MLN4924 for 1 
hr to inhibit the ubiquitination and degradation of pIκBα, and then sampled at indicated time 
points after TNFα treatment. The t1/2 of IκBα phosphorylation is estimated to be 14 min.  
(G-H) Concentration of endogenous IκBα is 10 times higher than endogenous β-TrCP. WB 
quantification of the endogenous IκBα (G) and β-TrCP (H) concentrations in WT cells, with 
recombinant GSTIκBα (G) and GSTβ-TrCP (H) spiked into cell lysate as the internal standards. 
Three biological replicates were analyzed on two individual gels as technical replicates. The 
concentration of IκBα was estimated to be 650 ± 66 nM (SD, n=6). The concentration of β-TrCP 
was estimated to be 64 ± 6 nM (SD, n=6). In other experiments, sample titration was performed 
to confirm that the band intensities measured here were within the linear range of the 
instrument.  
  
(I-K) pIκBα and β-TrCP form a very stable complex in cells. IP-WB analysis of the dissociation 
rate of the pIκBα•β-TrCP complex in cell lysate is shown in (I). DKO cell lysate containing 
3xFLAG tagged pIκBα with or without added recombinant Skp1∆∆•β-TrCP139-569 chase protein 
(~100x of endogenous β-TrCP level) was incubated at room temperature for indicated times. 
Dissociation of β-TrCP from pIκBα was calculated as ratios of β-TrCP to pIκBα signals in anti-
FLAG IPs, and these ratios were used to estimate koff (J) based on a fit to a single exponential. 
Lysate input for (I) is shown in (K). The amount of recombinant Skp1∆∆•β-TrCP139-569 chase 
protein added was in large excess of total endogenous Skp1•FBP complexes as judged by 
relative signals for Skp1 and Skp1∆∆. In addition, the level of endogenous β-TrCP in the lysate 
remained constant throughout a10-hr incubation at room temperature with or without added 
chase protein.   
 
Figure S4. Detailed reaction scheme of the SCF cycle model (related to Figure 4 and 
Method S1). 
(A) The scheme depicts the state variables and the reactions in the network as listed in Method 
S1 (Tables T2-T13 ). Fbox and S denote either Fb1 and S1 (relating to β-TrCP and pIκBα) or 
Fb2 and S2 (relating to auxiliary substrate receptors and their substrates). Lines with 
unidirectional arrows represent irreversible reactions. Reactions labeled by the same number 
(but different lower case letters) have the same kinetic parameters (Tables T3-T13 of Method 
S1).  Note that for better visibility some states are drawn twice in the network.  
(B) Reactions describing product inhibition of CSN by unneddylated Cul1 species. We assume 
that states in which Cul1 is not neddylated and its associated FBP is not bound to substrate, 
can bind CSN leading to the formation of complexes which are devoid of SCF ligase activity.  
(C) Illustration of the detailed balance relations for the thermodynamic cycles involving Cand1 
and FBP (lower cycle, K1K4 = K2K3), and Cand1 and Dcn1 (upper cycle , K8K5 = K3K9) (see 
Method S1 for details).  
 
Figure S5. Parameter identifiability analysis, response matrix, computation of protein 
fractions and cycle time (related to Figure 4, Figure 7 and Method S1). Experimental tests 
of the mathematical model predictions (related to Figure 5). 
(A) Profile likelihood as a function of estimated parameters (Table T15 of Method S1). Circles 
were determined by numerically computing the profile likelihood according to Eq. (S10). Red 
circles represent the optimal parameter values that minimize 𝜒2 as defined in Eq. (S9). Solid 
lines are smooth interpolations of the data points. Horizontal dotted lines represent thresholds 
  
as defined in Eq. (S11) that were used to derive 95% confidence intervals, either pointwise 
(lower line) or simultaneous (upper line).  
(B) Matrix of response coefficients as defined by Eq. (S12) (see Method S1). Parameters on the 
horizontal axis were increased by 10% and the relative change of different observable quantities 
(vertical axis) was computed. Positive / negative response coefficients indicate a positive / 
negative correlation between parameter and observable quantity. Absolute values larger 
(smaller) than 1 indicate a high (low) sensitivity with respect to the corresponding parameter. 
The greater the absolute value of a response coefficient, the more sensitive the respective 
quantity is to changes in the corresponding parameter. Parameters are defined in Table T15 of 
Method S1. The abbreviation “b2“ means “bound to“.  
(C) The scheme illustrates the computation of the coefficients defined in Eqs. (S13) and (S14) 
which determine the contribution of the encircled protein complexes to the protein fractions 
Cand1.b2.Cul1 and Skp1.b2.Cul1 as defined in Table T14 of Method S1. Note that these 
complexes are unstable (since they contain both Cand1 and FBP), and thus cannot be detected 
in our pull-down assays. Fb and S may denote Fb1 (β-TrCP) and S1 or Fb2 (auxiliary SRs) and 
S2.  
(D) Illustration of the computation of the cycle time according to Eq. (S21). Concentrations 
represent steady state concentrations of free (unbound) proteins obtained from simulations 
using parameters for WT cells (Table T2-T13, T15 of Method S1). Numbers in the table 
summarize the values of the on and off rate constants as well as the corresponding net rate 
constants (red color) computed from Eqs. (S15) - (S20).  
(E) Confirmation of β-TrCP overproduction in Fig 5C by WB analysis. Fold increase in total β-
TrCP levels are indicated. (dark): more intense exposure of β-TrCP blot. A 9-fold increase in 
total β-TrCP level in both WT and DKO cells was observed in a replicate experiment.   
(F) Overexpression of 3xFLAGCul1 reduces levels of unassembled cellular β-TrCP, Cand1 and 
Cand2. As depicted in Fig 5D, WT and DKO cells were treated with or without tetracycline to 
induce expression of a stably integrated 3xFLAGCul1 transgene, and then lysed in the presence of 
excess Cul1•GSTRbx1 to capture unassembled β-TrCP, Skp1, Cand1, and Cand2. Lysates were 
subjected to pulldown with glutathione beads, and bound fractions were subjected to WB with 
the indicated antibodies. One set of representative results from two replicate experiments are 
shown. These are the underlying data for the graph in Fig 5E. 
(G) Overproduction of β-TrCP modestly reduces the efficiency of its assembly with Cul1. As 
depicted in Fig 5F, WT and DKO cells with 3xFLAG-tagged endogenous Cul1 were treated with 
or without tetracycline to induce expression of a stably integrated β-TrCP transgene, and then 
  
lysed in the presence of excess Cul1•GSTRbx1 to suppress Cand1-mediated exchange and 
capture unassembled Skp1•β-TrCP complexes. Lysates were subjected to IP with anti-FLAG 
followed by pull-down with glutathione beads. Bound fractions were subjected to WB with the 
indicated antibodies. One set of representative results from two replicate experiments are 
shown. These are the underlying data for the graph in Fig 5G. 
 
Figure S6. FBP-dependent sequestration of Cul1 inhibits proliferation of DKO cells 
(related to Figure 6). 
(A-B) Fbxo6 overexpression further slows IκBα degradation rate in the DKO cells. These are the 
underlying data for the graph in Fig 6A. Cells were infected with lentiviruses to overproduce 
Fbxo6 and were subjected to TNFα treatment three days after the viral infection.  
(B) WB analysis of β-TrCP, HAFbxo6, and Skp1 in the cell lysates from panel (A). Relative 
protein levels are indicated below each blot.  
(C) Overproduction of HAFbxo6 decreases the endogenous SCFβ-TrCP. 3xFLAGCul1 was 
immunoprecipitated from WT and DKO cells overexpressing HAFbxo6 in the presence of 
recombinant Cul1•GSTRbx1 (+ sponge). Co-immunoprecipitated β-TrCP and HAFbxo6 were 
analyzed by WB.   
(D) Overexpression of Fbxo6 alters the morphology of DKO cells. Live cell images were 
acquired at 20x magnification seven days after viral infection.  
(E) WB with anti-Fbxo6 antibody showing HAFbxo6 overproduction five days after infection with 
recombinant lentivirus. The overproduction is estimated to be 45 times of the endogenous level.  
(F-I) Co-IP of 3xFLAGCul1 with overexpressed HAFbxo6ΔFbox (F), HAFbxl16 (G), HASkp2 (H), and 
HASkp2ΔLRR (I) in the presence of recombinant Cul1•GSTRbx1 (+ sponge). Cells were infected by 
lentiviruses to overexpress different FBPs, and the experimental procedures were similar to Fig 
6D. Long (L) and short (S) exposures of endogenous 3xFLAGCul1 are shown.  
(J) Quantification of the relative percent of Cul1 co-immunoprecipitated with overexpressed 
FBPs in (F-I), n = 2.  
 
Figure S7. FBP expression is dynamic during mouse development (related to Figure 6 
and Discussion).  
(A) Expression of FBP genes is highly variable during development of multiple tissues, despite 
stable expression of core SCF components. RNA-seq data from ENCODE for the indicated 
tissues during mouse development were normalized to ES cell expression levels. Fold change 
for each embryonic and birth timepoint relative to ES cells is presented in log10 scale. Each 
  
datapoint is derived from FPKM RNA-seq values and is the average of two replicates. Grey 
datapoints and lines represent expression of 73 FBPs, green represents SCF complex 
components (Cul1, Rbx1, Skp1, Cand1, and Cand2), and black represents the median fold 
change for all transcripts expressed in ES cells (25130 transcripts). 
(B) Expression of many FBPs is highly dynamic during development. RNA-seq data from 
ENCODE for mouse development was obtained as FPKM values, and averaged for two 
replicates. For selected FBPs, expression levels relative to total expression of 73 FBPs was 
calculated for each tissue and timepoint. Distinct colors represent different tissues as listed on 
the bottom, and bars in the same color represent different embryonic developmental timepoints 
from early organogenesis (leftmost; timepoint varies by tissue) to birth (rightmost). Tissues with 
only one timepoint represent gene expression at birth.   
 
 
 
METHOD S1: Mathematical model, related to Figure 4, Figure 7, Figure S4-S5 
Protein concentrations (HEK293 cells) 
Table T1 
protein concentration [nM] reference 
Cul1 522 
Reitsma et al. 2017 
Cand1 1210 
CSN (a) 378 
DCN1 325 
Skp1 2107 
Rbx1 1724 
Nedd8 (N8) 3373 
β-TrCP 64 this paper 
IκBα 647 this paper 
(a)
 average value of CSN1-CSN8 excluding CSN7 
 
Total DCN concentration 
In humans there are 5 DCN proteins (DCN1-5) all of which bind to Cul1 with similar affinity 
[Monda et al. (2013), Keuss et al. (2016)]. In addition, it seems that the 5 DCN proteins are 
partially functionally redundant so that the effective pool of catalytically active DCN proteins is 
likely to be larger than the DCN1 pool. To account for this effect in our model we defined the 
total DCN concentration by  
 
[𝐷𝐶𝑁] = 𝑓𝐷𝐶𝑁1 ∙ [𝐷𝐶𝑁1]. (S1) 
 
To estimate the scale factor 𝑓𝐷𝐶𝑁1 we note that in HeLa cells the total copy number of DCN 
proteins (DCN1-5) amounts to 256892 of which the sum of DCN1 and DCN2 equals 94931 
[Kulak et al., 2014]. Assuming that the concentrations of DCN1 and DCN2 are equal and that 
the relative proportions of DCN proteins in HEK 293 cells are similar to those in HeLa cells we 
obtain 𝑓𝐷𝐶𝑁1 = 256892/(94931/2) ≈ 5.4 which suggests that 5 ≤ 𝑓𝐷𝐶𝑁1 ≤ 6. In the simulations 
we used 𝑓𝐷𝐶𝑁1 = 6. 
 
Sequestration of Cand1, CSN and DCN1 by other cullins 
Cand1, CSN and DCN1 do not only bind to Cul1 but also to other cullins (Cul2-Cul5) in cullin-
RING ubiquitin ligases (CRLs) [Bennett et al., 2010] which reduces the amounts of Cand1, CSN 
and DCN1 that are available for binding to Cul1. To account for this effect in our model we 
defined effective Cand1, CSN and DCN1 concentrations through 
  
[𝐶𝑎𝑛𝑑1]𝑒𝑓𝑓 = 𝑓𝐶𝑎𝑛𝑑1,𝑊𝑇 ∙ [𝐶𝑎𝑛𝑑1] (S2) 
[𝐷𝐶𝑁1]𝑒𝑓𝑓 = 𝑓𝐷𝐶𝑁1,𝑊𝑇 ∙ [𝐷𝐶𝑁] (S3) 
[𝐶𝑆𝑁]𝑒𝑓𝑓 = 𝑓𝐶𝑆𝑁,𝑊𝑇 ∙ [𝐶𝑆𝑁] (S4) 
 
 
 
where [𝐶𝑎𝑛𝑑1], [𝐷𝐶𝑁] and [𝐶𝑆𝑁] are defined in Table T1 and Eq. (S1). Since DCN proteins bind 
cullins with similar affinity (within a factor of ~10) [Monda et al. (2013), Keuss et a. (2016)] we 
assumed that the scale factor 𝑓𝐷𝐶𝑁1,𝑊𝑇 is proportional to the relative abundance of Cul1, i.e. 
 
𝑓𝐷𝐶𝑁1,𝑊𝑇 =
[𝐶𝑢𝑙1]
[𝑅𝑏𝑥1] + [𝐶𝑢𝑙5]
=
522𝑛𝑀
1724𝑛𝑀 + 548𝑛𝑀
≈ 0.23. 
(S5) 
Here we used the concentration of Rbx1 (cf. Table T1) as a measure for the concentration of 
Cul1-Cul4 all of which form stable heterodimers with Rbx1 [Lydeard et al., 2013]. The 
concentration of Cul5 was extrapolated from the value reported in [Bennett et al., 2010] 
according to 
 
[𝐶𝑢𝑙5] =
[𝐶𝑢𝑙1]
[𝐶𝑢𝑙1]𝐵𝑒𝑛𝑛𝑒𝑡𝑡
[𝐶𝑢𝑙5]𝐵𝑒𝑛𝑛𝑒𝑡𝑡 ≈
522𝑛𝑀
302𝑛𝑀
317𝑛𝑀 ≈ 548𝑛𝑀. 
 
For simplicity, we used the same scale factor for CSN as for DCN defined in Eq. (S5), i.e. 
 
𝑓𝐶𝑆𝑁,𝑊𝑇 = 𝑓𝐷𝐶𝑁1,𝑊𝑇 ≈ 0.23. (S6) 
 
However, previous measurements have shown that if neddylation is inhibited the fraction of 
Cand1 associated with Cul1 is 0.4/0.75 ≈ 0.54 (Fig. S6 in [Bennett et al., 2010]) suggesting that 
more than half of the total Cand1 pool is associated with Cul1 under cellular conditions. Hence, 
we set 𝑓𝐶𝑎𝑛𝑑1,𝑊𝑇 = 0.54  in Eq. (S2). 
 
State variables and initial conditions 
Table T2 lists the state variables together with their initial values as used in our simulations. F-
box proteins (Fb) bind to Cul1 via the Skp1 adaptor protein. Due to the 1:1 stoichiometry 
between Skp1 and F-box proteins the total concentration of substrate receptors (Skp1•F-box 
dimers) is bounded by the availability of Skp1 proteins, i.e. [FbT] ≤ [Skp1] = 2107nM. In 
principle, it is conceivable that the amount of Skp1•F-box heterodimers is lower than the total 
amount of Skp1. However, to reduce the number of parameters that have to be estimated by 
comparing model simulations with experiments (cf. Parameter estimation) we set [FbT] = [Skp1]. 
 
Model reaction and rate constants 
We modeled the CRL cycle as a mass-action network. The network states together with the 
elementary reactions are depicted in Figs. S4A and S4B. The state variables together with their 
default initial values are defined in Table T2. Reversible reactions were parametrized by 𝑘𝑜𝑛 and 
𝑘𝑜𝑓𝑓 rate constants while irreversible reactions were parametrized by (pseudo) first-order rate 
constants. The latter may represent an effective 𝑘𝑐𝑎𝑡 (as for neddylation and deneddylation) or a 
specific degradation rate (as in the case of substrate degradation). Reactions with the same set 
of parameters are labelled by the same digit (1-16). Individual reactions within a group of 
reactions with the same set of parameters are distinguished by a lower case letter (a,b,c,…).  
 
In our model we considered two sets of F-box proteins, β-TrCP (Fb1) and auxiliary (background) 
substrate receptors (Fb2). In Fig. S4A and S4B only reactions involving Fb1 are shown. For 
each reaction involving Fb1 or S1 there exists a corresponding reaction for Fb2 or S2 which is 
listed in the tables below without an explicit reaction number. 
 
 
Table T2 
state variable IC(a) state variable IC state variable IC 
Cul1
(b)
 522 nM Cul1•Cand1 0 N8-Cul1•CSN 0 
Cand1
(b)
 1210 nM Cul1•Fb1 0 Cul1•DCN1•Fb1 0 
DCN1
(b)
 325 nM Cul1•Fb2 0 Cul1•DCN1•Fb2 0 
CSN
(b)
 378 nM Cul1•Fb1•S1 0 Cul1•DCN1•Fb1•S1 0 
FbT
(c)
 2107 nM Cul1•Fb2•S2 0 Cul1•DCN1•Fb2•S2 0 
Fb1
(b,d)
 64 nM Cul1•Cand1•Fb1 0 Cul1•Cand1•DCN1 0 
Fb2
(e,f)
 2043 nM Cul1•Cand1•Fb2 0 Cul1•Cand1•DCN1•Fb1 0 
Fb1•S1 0 Cul1•Cand1•Fb1•S1 0 Cul1•Cand1•DCN1•Fb2 0 
Fb2•S2 0 Cul1•Cand1•Fb2•S2 0 Cul1•Cand1•DCN1•Fb1•S1 0 
N8-Cul1 0 N8-Cul1•Fb1 0 Cul1•Cand1•DCN1•Fb2•S2 0 
Cul1•DCN1 0 N8-Cul1•Fb2 0 Cul1•Fb1•CSN 0 
Cul1•CSN 0 N8-Cul1•Fb1•S1 0 Cul1•Fb2•CSN 0 
S1 (IκBα-P) 0 N8-Cul1•Fb2•S2 0 Cul1•DCN1•CSN 0 
S2 (auxiliary) 0 N8-Cul1•Fb1•CSN 0 Cul1•DCN1•Fb1•CSN 0 
  N8-Cul1•Fb2•CSN 0 Cul1•DCN1•Fb2•CSN 0 
(a) 
initial condition, 
(b) 
measured, 
(c) 
[FbT] = [Skp1], 
(d) 
β-TrCP, 
(e) 
[Fb2] = [FbT] - [Fb1], 
(f) 
auxiliary substrate 
receptors 
 
F-box binding to Cul1 
The assembly of a functional Skp1•Cul1•F-box (SCF) complex requires binding of a Skp1•F-box 
heterodimer to Cul1. Here, we did not model the formation of Skp1•F-box dimers explicitly, but 
considered them as preformed stable entities [Schulman et al., 2000]. In general, there are ~69 
different SCF complexes in humans. In our model we considered only two types of Skp1•F-box 
proteins denoted by Fb1 and Fb2. This allows us to analyze the time scale for the degradation 
of a specific substrate (mediated by Fb1) in the presence of auxiliary substrate receptors (SRs). 
The latter compete with Fb1 for access to Cul1, and they are collectively denoted by Fb2. 
 
In a previous study the assembly of ~50 F-box proteins with Cul1 has been quantified under 
different conditions [Reitsma et al., 2017]. Under normal conditions occupancy ranged from 0% 
to 70% indicating a highly non-equilibrium steady state in vivo that is driven by neddylation, F-
box exchange and substrate availability. Even in the absence of neddylation occupancy ranged 
between 0% and 30% suggesting that there exists some variation in the expression level and/or 
the binding affinity of Cul1 for different F-box proteins. For the Skp1•Fbxw7 receptor 
biochemical studies yielded a dissociation constant of 0.225pM which increased by ~6 orders of 
magnitude to 650nM in the presence of Cand1 [Pierce et al., 2013]. This dramatic increase is 
mainly driven by a corresponding increase in the 𝑘𝑜𝑓𝑓 while the 𝑘𝑜𝑛 remained almost constant. 
In fact, modulating the off rate constant has been proposed as one of the main mechanisms 
through which cells may adjust their cellular SCF repertoire [Reitsma et al, 2017]. 
 
 
 
 
To allow β-TrCP (Fb1) to exhibit a different binding affinity from background SRs we fix 𝑘𝑜𝑛 at 
the values obtained for Fbxw7 and express the off rate constants for Fb1 and Fb2 in terms of 
those for Fbxw7 as  
 
𝑘𝑜𝑓𝑓,𝑖
𝐹𝑏1 = 𝑓𝐹𝑏1 ∙ 𝑘𝑜𝑓𝑓,𝑖
𝐹𝑏𝑥𝑤7   and    𝑘𝑜𝑓𝑓,𝑖
𝐹𝑏2 = 𝑓𝐹𝑏2 ∙ 𝑘𝑜𝑓𝑓,𝑖
𝐹𝑏𝑥𝑤7,    𝑖 = 1,2 (S7) 
where 𝑘𝑜𝑓𝑓,1
𝐹𝑏𝑥𝑤7 = 9 ∙ 10−7𝑠−1 and 𝑘𝑜𝑓𝑓,2
𝐹𝑏𝑥𝑤7 = 1.3𝑠−1 denote the off rate constants of Skp1•Fbxw7 
from the binary and ternary complexes (involving Cand1), respectively [Pierce et al., 2013]. The 
values of the two scale parameters 𝑓𝐹𝑏1  and 𝑓𝐹𝑏2  were estimated by comparing model 
predictions with experiments (cf. Parameter estimation and Table T15). 
 
Table T3 
No. Reactions involving Fb1 
𝑘𝑜𝑛 
(a) 
[(𝑀 ∙ 𝑠)−1] 
𝑘𝑜𝑓𝑓 
 [𝑠−1] 
1 Cul1 + Fb1 ↔ Cul1•Fb1 
4 ∙ 106 𝑓𝐹𝑏1 ∙ 9 ∙ 10
−7 
1a Cul1•DCN1 + Fb1 ↔ Cul1•DCN1•Fb1 
1b Cul1 + Fb1•S1 ↔ Cul1•Fb1•S1 
1c Cul1•DCN1 + Fb1•S1 ↔ Cul1•DCN1•Fb1•S1 
1d N8-Cul1 + Fb1 ↔ N8-Cul1•Fb1 
1e N8-Cul1 + Fb1•S1 ↔ N8-Cul1•Fb1•S1 
1f N8-Cul1•CSN + Fb1 ↔ N8-Cul1•Fb1•CSN 
2 Cul1•Cand1 + Fb1 ↔ Cul1•Cand1•Fb1 
2 ∙ 106 𝑓𝐹𝑏1 ∙ 1.3 
2a Cul1•Cand1•DCN1 + Fb1 ↔ Cul1•Cand1•DCN1•Fb1 
2b Cul1•Cand1 + Fb1•S1 ↔ Cul1•Cand1•Fb1•S1 
2c Cul1•Cand1•DCN1 + Fb1•S1 ↔ Cul1•Cand1•DCN1•Fb1•S1 
(a)
 measured for Skp1•Fbxw7 [Pierce et al., 2013] 
 
 
Table T4 
 Reactions involving Fb2 
𝑘𝑜𝑛  
[(𝑀 ∙ 𝑠)−1] 
𝑘𝑜𝑓𝑓 
 [𝑠−1] 
 Cul1 + Fb2 ↔ Cul1•Fb2 
4 ∙ 106 𝑓𝐹𝑏2 ∙ 9 ∙ 10
−7 
 Cul1•DCN1 + Fb2 ↔ Cul1•DCN1•Fb2 
 Cul1 + Fb2•S2 ↔ Cul1•Fb2•S2 
 Cul1•DCN1 + Fb2•S2 ↔ Cul1•DCN1•Fb2•S2 
 N8-Cul1 + Fb2 ↔ N8-Cul1•Fb2 
 N8-Cul1 + Fb2•S2 ↔ N8-Cul1•Fb2•S2 
 N8-Cul1•CSN + Fb2 ↔ N8-Cul1•Fb2•CSN 
 Cul1•Cand1 + Fb2 ↔ Cul1•Cand1•Fb2 
2 ∙ 106 𝑓𝐹𝑏2 ∙ 1.3 
 Cul1•Cand1•DCN1 + Fb2 ↔ Cul1•Cand1•DCN1•Fb2 
 Cul1•Cand1 + Fb2•S2 ↔ Cul1•Cand1•Fb2•S2 
 Cul1•Cand1•DCN1 + Fb2•S2 ↔ Cul1•Cand1•DCN1•Fb2•S2 
 
 
As suggested by our experiments (Fig. 2H) we modeled the assembly of SCF complexes by a 
random-order binding mechanism (Fig. S4A), i.e. Skp1•F-box receptor proteins may first bind to 
Cul1 species and then bind substrate or vice versa. In fact, previous simulations indicated that 
an exchange factor becomes dispensable if binding occurs in a sequential order, i.e. if substrate 
only binds to F-box proteins if the latter are already bound to Cul1 [Straube et al., 2017]. 
 
Cand1 binding to Cul1 
The exchange of Skp1•F-box proteins on Cul1 is catalyzed by Cand1 which acts as a substrate 
receptor exchange factor [Pierce et al., 2013]. Experiments suggest that Cand1 exerts its 
catalytic function similar to guanine nucleotide exchange factors (GEFs), i.e. through formation 
of a ternary (Cul1•Cand1•Fb) complex. In the absence of Skp1•F-box proteins spontaneous 
dissociation of Cand1 from a Cul1•Cand1 complex is extremely slow (𝑘𝑜𝑓𝑓,3 = 10
−5𝑠−1) but 
binding of Skp1•F-box to Cul1•Cand1 dramatically increases the dissociation constant for 
Cand1 in the ternary complex (reaction 4). On thermodynamic grounds (cf. Detailed balance 
relations) the increase of the dissociation constant for Cand1 upon binding of Skp1•F-box to 
Cul1•Cand1 must be the same as the increase of the dissociation constant for Skp1•F-box upon 
binding of Cand1 to Cul1•Skp1•F-box, i.e (cf. Fig. S4C) 
 
𝐾2
𝐾1
=
𝐾4
𝐾3
= 𝜏 (S8) 
where 𝐾𝑖 = 𝑘𝑜𝑓𝑓,𝑖/𝑘𝑜𝑛,𝑖 denotes the dissociation constant of reaction 𝑖. Substituting the known 
values for 𝐾1 (0.225𝑝𝑀)  and 𝐾2 (650𝑛𝑀)  we obtain 𝜏 ≈ 2.9 ∙ 10
6  which is comparable with 
values obtained for the GEF-mediated GDP/GTP exchange [Goody & Hofmann-Goody, 2002].  
 
To compute the remaining dissociation constants we measured the rate constants for the 
association between Cul1 and Cand1 (𝑘𝑜𝑛,3) and that between Cul1•Skp1•Skp2 and Cand1 
(𝑘𝑜𝑛,4) (cf. Fig. 1). In this way we obtained 𝐾3 = 0.5𝑝𝑀 and (using Eq. S8) 𝐾4 = (𝐾2/𝐾1)𝐾3 ≈
1.44𝜇𝑀. The latter also determines the dissociation rate constant 𝑘𝑜𝑓𝑓,4 as 
 
𝑘𝑜𝑓𝑓,4 = 𝑘𝑜𝑛,4 ∙ (𝐾2/𝐾1) ∙ 𝐾3 ≈ 2.9𝑠
−1. 
 
Reactions 5 and 6 describe the binding of Cand1 to Cul1 when DCN1 is already bound to Cul1. 
Our pulldown assay with immobilized DCN1 on GST beads showed (Fig. 3C and 3D) that in the 
presence of Cand1 the 𝐾𝐷 of DCN1 in the ternary Cul1•Cand1•DCN1 complex is reduced by a 
factor 𝛼 = 1/36 = 0.0278 (cf. Fig. S4C). To ensure that the 𝐾𝐷 for Cand1 in the ternary complex 
is reduced by the same factor we multiplied the 𝑘𝑜𝑓𝑓 for reaction 5 and 6 by 𝛼 and kept 𝑘𝑜𝑛 the 
same as for reactions 3 and 4 (Table T5). 
 
Substrate binding to F-box protein 
We assumed that substrate binds with equal affinity to free Skp1•F-box proteins as well as to 
Skp1•F-box proteins that are already bound to Cul1 (Cul1•Fb). In general, our model allows for 
two substrates that may differ in their binding parameters. In particular simulations S1 
represents the phosphorylated form of IκBα (IκBα-P) while S2 plays the role of auxiliary 
(background) substrate which is always present in cells. The off rate constant ( 𝑘𝑜𝑓𝑓~10
−5𝑠−1) 
for the dissociation of IκBα-P from Cul1•β-TrCP•IκBα-P is very small (cf. Fig. S5E) comparable 
 
 
to that for the dissociation of Skp1•F-box from an SCF complex. The on rate constant has not 
been measured, but is expected to lie between 106 − 107(𝑀 ∙ 𝑠)−1. In the simulations we used 
the value 𝑘𝑜𝑛 = 10
7(𝑀 ∙ 𝑠)−1 for both IκBα-P (S1) and auxiliary substrate (S2). Since the latter 
represents a mixture of different substrates (the type and amount of which is difficult to quantify 
for our experimental conditions) we assumed a less extreme value for the off rate constant of 
S2. The reactions involving S1 and S2 are listed in Table T6 and Table T7, respectively. 
 
Table T5  
No. Reactions 𝑘𝑜𝑛 [(𝑀 ∙ 𝑠)
−1] 𝑘𝑜𝑓𝑓 [𝑠
−1] 
3 Cul1 + Cand1 ↔ Cul1•Cand1 2 ∙ 107 (a) 10−5 (b) 
4 Cul1•Fb1 + Cand1 ↔ Cul1•Cand1•Fb1 
2 ∙ 106 (a) 2.9 (c) 
 Cul1•Fb2 + Cand1 ↔ Cul1•Cand1•Fb2 
4a Cul1•Fb1•S1 + Cand1 ↔ Cul1•Cand1•Fb1•S1 
 Cul1•Fb2•S2 + Cand1 ↔ Cul1•Cand1•Fb2•S2 
5 Cul1•DCN1 + Cand1 ↔ Cul1•Cand1•DCN1 2 ∙ 107 𝛼 ∙ 10−5 (d) 
6 Cul1•DCN1•Fb1 + Cand1 ↔ Cul1•Cand1•DCN1•Fb1 
2 ∙ 106 𝛼 ∙ 2.9 
 Cul1•DCN1•Fb2 + Cand1 ↔ Cul1•Cand1•DCN1•Fb2 
6a Cul1•DCN1•Fb1•S1 + Cand1 ↔ Cul1•Cand1•DCN1•Fb1•S1 
 Cul1•DCN1•Fb2•S2 + Cand1 ↔ Cul1•Cand1•DCN1•Fb2•S2 
(a)
 measured 
(b)
 measured [Pierce et al., 2013], 
(c)
 computed from Eq. (S8), 
(d) 𝛼 = 0.0278   
 
Table T6 
No. Reactions involving S1 𝑘𝑜𝑛 [(𝑀 ∙ 𝑠)
−1] 𝑘𝑜𝑓𝑓 [𝑠
−1] 
7 Fb1 + S1 ↔ Fb1•S1  
107 (a) 3.3 ∙ 10−5 (b) 
7a Cul1•Fb1 + S1 ↔ Cul1•Fb1•S1 
7b Cul1•Cand1•Fb1 + S1 ↔ Cul1•Cand1•Fb1•S1 
7c Cul1•DCN1•Fb1 + S1 ↔ Cul1•DCN1•Fb1•S1 
7d Cul1•Cand1•DCN1•Fb1 + S1 ↔ Cul1•Cand1•DCN1•Fb1•S1 
7e N8-Cul1•Fb1 + S1 ↔ N8-Cul1•Fb1•S1 
(a) estimated, (b) measured 
 
Table T7 
No. Reactions involving S2 𝑘𝑜𝑛 [(𝑀 ∙ 𝑠)
−1] 𝑘𝑜𝑓𝑓 [𝑠
−1] 
 Fb2 + S2 ↔ Fb1•S2 
107 (a) 0.01 (a) 
 Cul1•Fb2 + S2 ↔ Cul1•Fb2•S2 
 Cul1•Cand1•Fb2 + S2 ↔ Cul1•Cand1•Fb2•S2 
 Cul1•DCN1•Fb2 + S2 ↔ Cul1•DCN1•Fb2•S2 
 Cul1•Cand1•DCN1•Fb2 + S2 ↔ Cul1•Cand1•DCN1•Fb2•S2 
 N8-Cul1•Fb2 + S2 ↔ N8-Cul1•Fb2•S2 
(a)
 estimated 
 
 
 
DCN1 binding to Cul1 
DCN1 is a scaffold-like E3 ligase which is required for efficient Cul1 neddylation [Kurz et al., 
2008]. Experiments have shown that DCN1 forms a stable ternary complex with Cul1 and 
Cand1 [Keuss et al., 2016]. In the absence of Cand1 the 𝐾𝐷  for DCN1 binding to Cul1 is 
comparably low (1.8µ𝑀) [Monda et al., 2013] while binding of Cand1 increases the affinity of 
DCN1 to Cul1 36-fold (Fig. 3C and 3D), i.e. the 𝐾𝐷 is lowered by a factor 𝛼 = 1/36 = 0.0278 (cf. 
Cand1 binding to Cul1). To generate a 𝐾𝐷  of 1.8µ𝑀  we set 𝑘𝑜𝑛 = 10
6 (𝑀 ∙ 𝑠)−1  and 𝑘𝑜𝑓𝑓 =
1.8 𝑠−1 (Table T8). When Cand1 is bound to Cul1 we keep 𝑘𝑜𝑛, but lower 𝑘𝑜𝑓𝑓 by a factor 𝛼.  
 
Table T8 
No. Reactions 𝑘𝑜𝑛 [(𝑀 ∙ 𝑠)
−1] 𝑘𝑜𝑓𝑓 [𝑠
−1] 
8 Cul1 + DCN1 ↔ Cul1•DCN1  
106 (a) 1.8 (b) 
8a Cul1•Fb1 + DCN1 ↔ Cul1•DCN1•Fb1 
 Cul1•Fb2 + DCN1 ↔ Cul1•DCN1•Fb2 
8b Cul1•Fb1•S1 + DCN1 ↔ Cul1•DCN1•Fb1•S1 
 Cul1•Fb2•S2 + DCN1 ↔ Cul1•DCN1•Fb2•S2 
9 Cul1•Cand1 + DCN1 ↔ Cul1•Cand1•DCN1 
106 α∙ 1.8 (c) 
9a Cul1•Cand1•Fb1 + DCN1 ↔ Cul1•Cand1•DCN1•Fb1 
 Cul1•Cand1•Fb2 + DCN1 ↔ Cul1•Cand1•DCN1•Fb2 
9b Cul1•Cand1•Fb1•S1 + DCN1 ↔ Cul1•Cand1•DCN1•Fb1•S1 
 Cul1•Cand1•Fb2•S2 + DCN1 ↔ Cul1•Cand1•DCN1•Fb2•S2 
(a)
 estimated, 
(b)
 adjusted so that 𝐾𝐷 = 1.8µ𝑀 [Monda et al., 2013], 
(c)
 α=0.0278 
 
Detailed balance relations 
The CRL network contains several thermodynamic cycles two of which are depicted in Fig. S4C. 
Since each of these cycles comprises only of reversible equilibria there must be no net flux in 
each cycle at steady state. In physical terms, this means that the change in free energy for the 
formation of the ternary complexes (Cul1•Cand1•Fb and Cul1•Cand1•DCN1) must not depend 
on the order in which they are formed. This constraint leads to detailed balance relations 
between the dissociation constants in each cycle, i.e. 𝐾1 ∙ 𝐾4 = 𝐾2 ∙ 𝐾3 and 𝐾3 ∙ 𝐾9 = 𝐾5 ∙ 𝐾8. A 
similar relation also holds for the cycle comprising the reactions 4, 6, 8a, and 9a which leads to 
𝐾4 ∙ 𝐾9 = 𝐾8 ∙ 𝐾6.  
 
Neddylation reactions 
Since DCN1 is required for efficient neddylation of Cul1 [Kurz et al., 2008] and since Cand1 
binding and N8 conjugation cannot occur simultaneously [Liu et al., 2002] we assumed that 
neddylation can only occur from SCF states where DCN1 is bound to Cul1 and Cand1 is not 
bound to Cul1. In general, Nedd8 (N8) conjugation is catalyzed by an associated E2 enzyme 
(e.g. UBC12) which is recruited to the Rbx1 domain of an SCF complex. However, the rate 
constants for E2 binding and N8 conjugation are not known. To keep the number of unknown 
parameters as small as possible we model neddylation by a first order process (Table T9) with 
effective neddylation rate constant 𝑘𝑛𝑒𝑑𝑑  which is treated as a variable parameter to be 
estimated from experiments (cf. Table T15). Also, since the concentration of N8 is much larger 
 
 
than that of the other proteins (cf. Table T1) we assumed that N8 is not limiting for the reaction 
so that it can be absorbed into the definition of the rate constant.  
 
Table T9 
No. Reactions 𝑘𝑛𝑒𝑑𝑑 [𝑠
−1] 
10 Cul1•DCN1 → N8-Cul1 + DCN1  
0.268 (a) 
10a Cul1•DCN1•Fb1 → N8-Cul1•Fb1 + DCN1 
 Cul1•DCN1•Fb2 → N8-Cul1•Fb2 + DCN1 
10b Cul1•DCN1•Fb1•S1 → N8-Cul1•Fb1•S1 + DCN1 
 Cul1•DCN1•Fb2•S2 → N8-Cul1•Fb2•S2 + DCN1 
(a)
 estimated 
 
Deneddylation reactions 
Deneddylation is mediated by the COP9 signalosome (CSN). Consistent with measurements of 
the rate constants for CSN-mediated deneddylation of N8-Cul1 [Mosadeghi et al., 2016] we 
assumed that CSN first binds reversibly to N8-Cul1 and N8-Cul1•Fb (11 and 11a) and, in a 
second step, N8 is cleaved leading to the dissociation of CSN (12 and 12a).  
 
Table T10 
No. Reactions 𝑘𝑜𝑛 [(𝑀 ∙ 𝑠)
−1] 𝑘𝑜𝑓𝑓 [𝑠
−1] 𝑘𝑐𝑎𝑡 [𝑠
−1] 
11 N8-Cul1 + CSN ↔ N8-Cul1•CSN  
2 ∙ 107 (a) 0.032 (a)  11a N8-Cul1•Fb1 + CSN ↔ N8-Cul1•Fb1•CSN 
 N8-Cul1•Fb2 + CSN ↔ N8-Cul1•Fb2•CSN 
12 N8-Cul1•CSN → Cul1 + CSN  
  1.1 (a) 12a N8-Cul1•Fb1•CSN → Cul1•Fb1 + CSN 
 N8-Cul1•Fb2•CSN → Cul1•Fb2 + CSN 
(a)
 measured [Mosadeghi et al., 2016] 
 
 
Product inhibition of CSN 
While neddylated Cul1 is a substrate of the CSN deneddylated Cul1 acts as an inhibitor of CSN 
activity [Mosadeghi et al., 2016]. CSN binds to both neddylated and deneddylated Cul1, but with 
different binding affinity. While the 𝑘𝑜𝑛  is the same for both reactions the 𝑘𝑜𝑓𝑓  for CSN in 
complex with non-neddylated Cul1 is increased by a factor of ~200. Previous biochemical 
analysis has shown that, in the presence of Cand1 or substrate, the deneddylation rate is 
reduced [Emberley et al., 2012]. Moreover, addition of substrate impedes stable association of 
CSN with SCF [Enchev et al., 2012]. Hence, to model product inhibition of CSN we assumed 
that CSN only binds to Cul1, Cul1•Fb, Cul1•DCN1 and Cul1•DCN1•Fb states (cf. Table T11). 
 
 
 
 
 
 
 
 
Table T11 
No. Reactions 𝑘𝑜𝑛 [(𝑀 ∙ 𝑠)
−1] 𝑘𝑜𝑓𝑓 [𝑠
−1] 
13 Cul1 + CSN ↔ Cul1•CSN  
2 ∙ 107 (a) 6.2 (a) 
13a Cul1•Fb1 + CSN ↔ Cul1•Fb1•CSN 
 Cul1•Fb2 + CSN ↔ Cul1•Fb2•CSN 
13b Cul1•DCN1 + CSN ↔ Cul1•DCN1•CSN  
13c Cul1•DCN1•Fb1 + CSN ↔ Cul1•DCN1•Fb1•CSN 
 Cul1•DCN1•Fb2 + CSN ↔ Cul1•DCN1•Fb2•CSN 
(a)
 measured [Mosadeghi et al., 2016] 
 
Substrate degradation 
Substrate degradation by itself is a complex process which involves recruitment of Ub-loaded 
E2 enzyme to the Rbx1 domain of an SCF complex, subsequent multiple Ub transfers to the 
substrate and processing by the 26S proteasome. Here, we neglected much of this complexity 
and assumed that once a substrate-bound SCF complex is neddylated the substrate can be 
degraded. The latter process was described by first order rate constant 𝑘𝑑𝑒𝑔 which summarizes 
the above mentioned processes in an effective manner (Table T12). Also, for simplicity we 
assumed that the degradation rate constant is the same for S1 (IκBα-P) and background 
substrate S2. For the human 26S proteasome substrate degradation rates range from less than 
0.01 𝑚𝑖𝑛−1 up to 0.7 𝑚𝑖𝑛−1 depending on the substrate and the number of conjugated ubiquitins 
[Lu et al., 2016]. For CyclinB-NT with 4 conjugated ubiquitins the degradation rate is 0.5 𝑚𝑖𝑛−1 
or 0.0083 𝑠−1. Based on our measurements we estimated 𝑘𝑑𝑒𝑔 = 0.0071 𝑠
−1 (cf. Table T15). 
 
Table T12 
No. Reactions 𝑘𝑑𝑒𝑔 [𝑠
−1] 
14 N8-Cul1•Fb1•S1 → N8-Cul1•Fb1  
0.0071 (a) 
 N8-Cul1•Fb2•S2 → N8-Cul1•Fb2 
(a)
 estimated 
 
Background substrate 
To generate the high degree of Cul1 neddylation observed experimentally we had to assume 
that cells contain a certain amount of CRL substrates, which is consistent with the fact that 
substrate favors the neddylated state of CRL ligases [Emberley et al., 2012;  Enchev et al., 
2012]. To generate auxiliary substrate we assumed a constitutive synthesis term (Table T13). 
Since the total amount of background CRL substrates in the cell is unknown we treated the 
synthesis rate as a variable parameter to be determined by comparison with experiments (cf. 
Table T15). In this way we obtained an estimate of 2261nM for the concentration of background 
substrate under steady state conditions in wildtype cells assuming that substrates are only 
degraded via the CRL-mediated pathway. 
 
Table T13  
No. reaction 𝑘𝑠𝑦𝑛𝑡ℎ
𝑆2  [𝑛𝑀 ∙ 𝑠−1] 
15 Ø → S2 1.4 (a) 
(a) 
estimated 
 
 
Simulations were done with the Systems Biology Toolbox of MATLAB [MATLAB 2015b] which 
was used to translate the model reactions (1-15) into a system of ordinary differential equations 
using mass-action kinetics. Integrations were performed with the implicit solver ode15s. 
 
Parameter estimation 
To validate our model we measured different quantities in wildtype (WT) cells as well as in 
response to different genetic perturbations (cf. Table T14). Conditions listed in bold font were 
used to estimate the values of unknown parameters. Altogether, our model comprises 54 state 
variables and 35 parameters (rate constants, protein concentrations and scale parameters) from 
which 22 parameters were either known from previous experiments or measured in this work. 
Among the 13 remaining parameters 8 parameters could be reasonably estimated or 
constrained leaving only 5 parameters to be fitted by comparing model simulations with 
experiments. The 4 scale factors P1 – P4 (Table T15) were estimated based on relative protein 
abundances and previous measurements of the association of Cand1 with different cullins. The 
4 on and off rate constants P5 – P8 had almost no effect on the value of the measured 
quantities (cf. T14 and Fig. S5B), so we fixed them at the indicated values to reduce the number 
of variable parameters during the fitting procedure.  
 
Table T14 – Experimental conditions and measured quantities 
measured quantity cell type / perturbation / condition type of experiment figure 
Cul1.b2.Cand1
(a)
 WT
(e)
 / WT + MLN4924 steady state 4B 
Cul1.b2.Skp1
(b) WT / WT + MLN4924 / DKO
(f)
 steady state 4B 
Cul1.b2.N8
(c) WT / WT + Cul1 / DKO / DKO + Cul1 steady state 4E 
β-TrCP.b2.Cul1
(d) 
WT steady state 4D 
𝑡1/2 
WT / DKO / DKO + Cand1 
transient 
4C 
WT + β-TrCP / WT + Cul1 / 
DKO + β-TrCP / DKO + Cul1 
4F 
(a)
 fraction of Cul1 bound to Cand1, 
(b)
 fraction of Cul1 bound to Skp1,
 (c)
 fraction of Cul1 bound to Nedd8,  
(d)
 fraction of β-TrCP bound to Cul1, 
(e)
 WT – wildtype, 
(f)
 DKO – double knockout Cand1
-/-
, Cand2
-/- 
 
To estimate the values of the 5 remaining parameters in Table T15 (P9-P13) we used nonlinear 
optimization in combination with a profile likelihood approach as described in [Raue et al., 
2009]. To calibrate the model we defined the weighted sum of squared residuals as an objective 
function  
 
 
𝜒2(𝜃) ≔ ∑
(𝑦𝑘 − 𝑦𝑘(𝜃))
2
𝜎𝑘
2
6
𝑘=1
 
(S9) 
 
and numerically determined 𝜃 = (𝑓
𝐹𝑏1
, 𝑓
𝐹𝑏2
, 𝑘𝑛𝑒𝑑𝑑, 𝑘𝑑𝑒𝑔, 𝑘𝑠𝑦𝑛𝑡ℎ
𝑆2 ) such that  
 
𝜃 = argmin [𝜒2(𝜃)]. 
 
In Eq. (S9)  𝑦𝑘 and 𝜎𝑘
2 denote the values of the measured quantities (cf. T14, bold face) and 
their respective measurement errors. The quantities 𝑦𝑘(𝜃)  are the predicted values of the 
measured quantities obtained from numerical simulations of our model for a particular set of 
parameter values. Due to limited sample size we were not able to reliably estimate the 
measurement errors from the data. So, for convenience, we assumed equal variances of 
 
 
𝜎𝑘
2 = 0.1𝑦𝑘 (10% from the mean values) for all measurements. However, since all parameters 
are identifiable (see below) a different choice for the values of the variances would yield 
qualitatively similar results. 
 
To obtain confidence intervals for the estimated parameter values we numerically computed the 
profile likelihood for each parameter defined as 
 
𝜒𝑃𝐿
2 (𝜃𝑖) = min𝜃𝑗≠𝑖[𝜒
2(𝜃)], (S10) 
i.e. for each value of 𝜃𝑖 the objective function defined in Eq. (S9) was re-optimized with respect 
to the remaining parameters 𝜃𝑗≠𝑖 . The resulting plots exhibit a parabolic shape (Fig. S5A) 
indicating that all parameters are identifiable [Raue et al., 2009]. To obtain finite sample 
confidence intervals we defined the confidence regions 
 
{𝜃𝑖: 𝜒𝑃𝐿
2 (𝜃) − 𝜒2(𝜃) < 𝛥𝛼}, 𝑖 = 1, … ,5 
(S11) 
where the threshold 𝛥𝛼 = 𝜒
2(𝛼, 𝑑𝑓) is the 𝛼 quantile (confidence level) of the 𝜒2-distribution with 
𝑑𝑓 degrees of freedom. Pointwise confidence intervals are obtained for 𝑑𝑓 = 1 while 𝑑𝑓 = 5 
yields simultaneous confidence intervals for all 5 parameters. Confidence intervals for model 
predictions (cf. Fig. 4) were computed by running simulations for parameters sampled from the 
confidence region defined by Eq. (S11) with the threshold  𝛥𝛼 = 𝜒
2(0.95,5) (Fig. S5A, upper 
horizontal line).  
 
Table T15 – List of estimated parameters 
parameter value expected range defined in fixed / variable 
P1 𝑓𝐷𝐶𝑁1 6 5 − 6 Eq. (S1) fixed 
P2 
P3 
𝑓𝐷𝐶𝑁1,𝑊𝑇 
𝑓𝐶𝑆𝑁,𝑊𝑇 
0.23  
Eqs. (S2) – (S4) 
fixed 
P4 𝑓𝐶𝑎𝑛𝑑1,𝑊𝑇 0.54  fixed 
P5 𝑘𝑜𝑛
𝑆1  107 (𝑀𝑠)−1 106 − 107 (𝑀𝑠)−1 Table T6  fixed 
P6 𝑘𝑜𝑛
𝑆2  107 (𝑀𝑠)−1 106 − 107 (𝑀𝑠)−1 Table T7 fixed 
P7 𝑘𝑜𝑓𝑓
𝑆2  0.01𝑠−1 0.0001 − 0.01 𝑠−1 Table T7 fixed 
P8 𝑘𝑜𝑛
𝐷𝐶𝑁1 106 (𝑀𝑠)−1 106 − 107 (𝑀𝑠)−1 Table T8 fixed 
P9 𝑓𝐹𝑏1 0.247 0.102 − 0.490 
(a)
 Eq. (S7) variable  
P10 𝑓𝐹𝑏2 6.514 2.978 − 17.461 
(a)
 Eq. (S7) variable 
P11 𝑘𝑛𝑒𝑑𝑑 0.268 𝑠
−1 0.134 − 0.626 𝑠−1 (a) Table T9 variable 
P12 𝑘𝑑𝑒𝑔 0.0071 𝑠
−1 0.0055 − 0.0091 𝑠−1 (a) Table T12 variable 
P13 𝑘𝑠𝑦𝑛𝑡ℎ
𝑆2  1.40 𝑛𝑀 ∙ 𝑠−1 1.09 − 1.85 𝑛𝑀 ∙ 𝑠−1 (a) Table T13 variable 
(a)
 simultaneous confidence intervals to a 95% confidence level with 10% assumed measurement errors. 
 
Response coefficients 
To quantify how small changes in one of the parameters (P5 – P13) would impact the predicted 
values for the measured quantities (cf. T14) we computed the matrix of response coefficients 
(Fig. S5B) according to 
 
 
 
𝑅𝑖𝑗 ≔
∆𝑄𝑖/𝑄𝑖
𝑟𝑒𝑓
∆𝑃𝑗/𝑃𝑗
𝑟𝑒𝑓
 
(S12) 
where ∆𝑃𝑗 = 𝑃𝑗 − 𝑃𝑗
𝑟𝑒𝑓
 denotes the change of parameter 𝑃𝑗  relative to a reference value 𝑃𝑗
𝑟𝑒𝑓
 
and ∆𝑄𝑖 = 𝑄𝑖 − 𝑄𝑖
𝑟𝑒𝑓
 represents the corresponding change of the predicted quantity 𝑄𝑖 . 
Depending on whether 𝑄𝑖 increases or decreases upon a parameter change ∆𝑃𝑗 the response 
coefficient 𝑅𝑖𝑗 may be positive or negative, respectively. Its magnitude quantifies the fractional 
change of 𝑄𝑖 upon a fractional change of 𝑃𝑗. The fact that almost all response coefficients satisfy 
|𝑅𝑖𝑗| < 1 means that our system exhibits only a weak sensitivity to most of the parameters at the 
respective reference point. This is particularly true for the 4 on and off rate constants P5 – P8 
which have almost no effect on the predicted values of the measured quantities except for 𝑘𝑜𝑛
𝐷𝐶𝑁 
which weakly affects the half-life for substrate degradation in DKO cells. To reduce the number 
of fitting parameters we have, therefore, fixed P5 – P8 during parameter estimation.  
 
From the entries of the response matrix for the remaining parameters (P9 – P13) we can make 
some interesting observations: The fractions of Cul1 bound to Cand1, Skp1 and Nedd8 (first 
three rows) are mainly determined by the ratio between substrate synthesis ( 𝑘𝑠𝑦𝑛𝑡ℎ
𝑆2 ) and 
degradation (𝑘𝑑𝑒𝑔). If the substrate synthesis rate is increased the neddylated fraction of Cul1 
increases and more Skp1•F-box proteins are recruited to Cul1 leading to a reduction of the 
fraction of Cul1 associated with Cand1. Increasing 𝑘𝑑𝑒𝑔 has the opposite effect. However, the 
latter also affects the half-life for IκBα degradation while 𝑘𝑠𝑦𝑛𝑡ℎ
𝑆2  has only a minor effect on 𝑡1/2. 
Interestingly the total concentration of Skp1•F-box proteins (FbT) has a strong positive effect on 
the half-life for IκBα degradation in DKO cells because increasing the total pool of F-box 
proteins reduces the amount of Cul1 available for binding to β-TrCP.  
 
Protein fractions in terms of state variables 
To relate the measured quantities defined in Table T14 to state variables in our model (cf. Table 
2) we used the following relations: The fraction of Cul1 bound to Nedd8 was computed as 
 
Cul1. b2. N8 =
[N8˗Cul1] + [N8˗Cul1 • Fb1] + [N8˗Cul1 • Fb2]
Cul1T
+
[N8˗Cul1 • Fb1 • S1] + [N8˗Cul1 • Fb2 • S2] + [N8˗Cul1 • CSN]
Cul1T
+
[N8˗Cul1 • Fb1 • CSN] + [N8˗Cul1 • Fb2 • CSN]
Cul1T
 
 
where 𝐶𝑢𝑙1𝑇 denotes the total concentration of Cul1 defined in Table T1. To define the fractions 
of Cul1 bound to Cand1 (Cul1.b2.Cand1) and Cul1 bound to Skp1•F-box (Cul1.b2.Skp1) we had 
to take into account that higher-order complexes involving Cand1 and Fb1 or Fb2 are unstable 
and, thus, cannot be detected in our pull-down assays. For example, the complexes 
Cul1•Cand1•Fbi•Si would rapidly decay into Cul1•Fbi•Si and Cand1 or Cul1•Cand1 and Fbi•Si 
(Fig. S5C). The corresponding probabilities are given by 
 
𝑎𝑖 =
𝑘𝑜𝑓𝑓,2
𝑆𝑖
𝑘𝑜𝑓𝑓,2
𝑆𝑖 + 𝑘𝑜𝑓𝑓,4
 and 𝑏𝑖 = 1 − 𝑎𝑖 =
𝑘𝑜𝑓𝑓,4
𝑘𝑜𝑓𝑓,2
𝑆𝑖 + 𝑘𝑜𝑓𝑓,4
, 𝑖 = 1,2 (S13) 
 
 
 
where the rate constants 𝑘𝑜𝑓𝑓,2
𝑆𝑖  and 𝑘𝑜𝑓𝑓,4  are defined in Tables T3-T5. For the decay of 
complexes involving Cand1, DCN1 and Fb1 or Fb2 we considered three decay channels as the 
dissociation of Cand1 and DCN1 from Cul1•Cand1•DCN1•Fbi•Si or Cul1•Cand1•DCN1•Fbi 
occurs with similar rates. The respective probabilities are given by 
 
𝑐𝑖 =
𝑘𝑜𝑓𝑓,2
𝑆𝑖
𝑘𝑜𝑓𝑓,2
𝑆𝑖 + 𝑘𝑜𝑓𝑓,6 + 𝑘𝑜𝑓𝑓,9
, 𝑑𝑖 =
𝑘𝑜𝑓𝑓,6
𝑘𝑜𝑓𝑓,2
𝑆𝑖 + 𝑘𝑜𝑓𝑓,6 + 𝑘𝑜𝑓𝑓,9
, 𝑒𝑖 = 1 − (𝑐𝑖 + 𝑑𝑖),  (S14) 
 
for 𝑖 = 1,2  where the rate constants 𝑘𝑜𝑓𝑓,6  and 𝑘𝑜𝑓𝑓,9  are defined in Tables T5 and T8, 
respectively. With the help of these probabilities the protein fractions Cul1.b2.Cand1 and 
Cul1.b2.Skp1 (which we set equal to Cul1.b2.Fb1+Cul1.b2.Fb2) are defined by  
 
Cul1. b2. Cand1 =
[Cul1 • Cand1] + 𝑎1([Cul1 • Cand1 • Fb1] + [Cul1 • Cand1 • Fb1 • S1])
Cul1T
+
𝑎2([Cul1 • Cand1 • Fb2] + [Cul1 • Cand1 • Fb2 • S2]) + [Cul1 • Cand1 • DCN1]
Cul1T
+
(𝑎1𝑒1 + 𝑐1)([Cul1 • Cand1 • DCN1 • Fb1] + [Cul1 • Cand1 • DCN1 • Fb1 • S1])
Cul1T
+
(𝑎2𝑒2 + 𝑐2)([Cul1 • Cand1 • DCN1 • Fb2] + [Cul1 • Cand1 • DCN1 • Fb2 • S2])
Cul1T
 
and 
 
Cul1. b2. Fbi =
[Cul1 • Fbi] + [Cul1 • Fbi • Si] + [Cul1 • DCN1 • Fbi]
Cul1T
+
𝑏𝑖([Cul1 • Cand1 • Fbi] + [Cul1 • Cand1 • Fbi • Si])
Cul1T
+
(𝑏𝑖𝑒𝑖 + 𝑑𝑖)([Cul1 • Cand1 • DCN1 • Fbi] + [Cul1 • Cand1 • DCN1 • Fbi • Si])
Cul1T
+
[N8˗Cul1 • Fbi] + [N8˗Cul1 • Fbi • Si] + [N8˗Cul1 • Fbi • CSN]
Cul1T
+
[Cul1 • DCN1 • Fbi • CSN] + [Cul1 • Fbi • CSN] + [Cul1 • DCN1 • Fbi • Si]
Cul1T
 
 
for 𝑖 = 1,2. The fraction of β-TrCP bound to Cul1 (β-TrCP.b2.Cul1) is given by 
 
β˗TrCP. b2. Cul1 = Cul1. b2. Fb1
Cul1T
Fb1T
 
 
where Fb1T equals the total β-TrCP concentration listed in Table T1. 
 
Simulation protocols 
To simulate IκBα degradation of we started simulations from steady state by adding the reaction 
 
No. reaction 𝑘𝑝ℎ𝑜𝑠 [𝑠
−1] initial condition 
16 IκBα → IκBα-P (S1) ln(2) /(60 ∙ 14) [IκBα]=647nM 
 
 
 
which describes the phosphorylation of IκBα by IκBα kinase. Phosphorylated IκBα (IκBα-P) is 
generated with a half-life of 14min serving as a substrate of the SCFβ-TrCP ligase (Cul1 • Fb1). 
 
To simulate the conditions and perturbations listed in Table T14 we used the protocols defined in 
Table T16. Inhibition of Nedd8 conjugation as well as Cand1-/-, Cand2-/- double knockout were 
simulated by setting the neddylation rate constant and the total Cand1 concentration to zero, 
respectively. To simulate Cul1 overexpression we computed a scale factor assuming that Cul1 
competes with other cullins for access to Rbx1. Similarly, to simulate β-TrCP overexpression we 
computed a scale factor assuming that β-TrCP competes with auxiliary SRs for access to Skp1. 
In the case of Cul1 overexpression we also had to recompute the scale factors that account for 
sequestration of DCN1, CSN and Cand1 by other cullins. In both cases the overexpression 
factors (𝑓𝐶𝑢𝑙1 and 𝑓β˗TrCP) account for both endogenous and exogenous proteins. 
 
Table T16 
perturbation protocol remark 
WT + MLN4924 set 𝑘𝑛𝑒𝑑𝑑 = 0 at 𝑡 = 0 
Inhibition of Nedd8 
conjugation 
DKO set [𝐶𝑎𝑛𝑑1] = 0 at 𝑡 = 0 
Cand1
-/-
, Cand2
-/-
 
double knockout 
WT / DKO + Cul1 
set [𝐶𝑢𝑙1]𝑂𝐸 = 𝑓𝑂𝐸,𝐶𝑢𝑙1 ∙ [𝐶𝑢𝑙1]𝑊𝑇
(𝑎)
 with 
 
𝑓𝑂𝐸,𝐶𝑢𝑙1
(𝑏) =
𝑓𝐶𝑢𝑙1[𝑅𝑏𝑥1]
[𝑅𝑏𝑥1] + (𝑓𝐶𝑢𝑙1 − 1)[𝐶𝑢𝑙1]𝑊𝑇
 
 
and recompute scale factors in Eqs. (S2) – (S4)  
 
𝑓𝐷𝐶𝑁1,𝑂𝐸
(𝑐) =
[𝐶𝑢𝑙1]𝑂𝐸
[𝐶𝑢𝑙1]𝑂𝐸 + [𝑅𝑏𝑥1] − [𝐶𝑢𝑙1]𝑊𝑇 + [𝐶𝑢𝑙5]
 
 
𝑓𝐶𝑎𝑛𝑑1,𝑂𝐸
(𝑑) = 𝑚𝑖𝑛 (1, 𝑓𝐶𝑎𝑛𝑑1,𝑊𝑇
𝑓𝐷𝐶𝑁1,𝑂𝐸
𝑓𝐷𝐶𝑁1,𝑊𝑇
) 
 
Cul1 overexpres-
sion in WT or DKO 
WT / DKO + β-TrCP 
set [𝐹𝑏1]𝑂𝐸 = 𝑓𝑂𝐸,β˗TrCP ∙ [𝐹𝑏1]𝑊𝑇
(𝑒)
 with 
 
𝑓𝑂𝐸,β˗TrCP
(𝑓) =
𝑓β˗TrCP[𝐹𝑏𝑇]𝑊𝑇
[𝐹𝑏𝑇]𝑊𝑇 + (𝑓β˗TrCP − 1)[𝐹𝑏1]𝑊𝑇
 
 
set [𝐹𝑏𝑇]𝑂𝐸 = [𝐹𝑏𝑇]𝑊𝑇 − [𝐹𝑏1]𝑂𝐸 
β-TrCP overex-
pression in WT or 
DKO 
(a)
 [𝐶𝑢𝑙1]𝑊𝑇 = 522𝑛𝑀,  
(b)  𝑓𝐶𝑢𝑙1 = 6.6 in WT and 𝑓𝐶𝑢𝑙1 = 5 in DKO, 
(c)
  𝑓𝐶𝑆𝑁,𝑂𝐸 = 𝑓𝐷𝐶𝑁1,𝑂𝐸 , 
(d)
 not applicable in 
DKO, 
(e)
 [𝐹𝑏1]𝑊𝑇 = 64𝑛𝑀, 
(f)  𝑓β˗TrCP = 5.5 in WT and 𝑓β˗TrCP = 8 in DKO, [𝐹𝑏𝑇]𝑊𝑇 = 2107𝑛𝑀 
 
Computation of the cycle time 
To compute the cycle time for the cyclic reaction chain depicted in Fig. 7 we assigned to each 
reversible reaction an effective forward rate constant using the concept of net rate constants 
[Cleland, 1975]. The latter are denoted by 𝑘1,…,𝑘6 in Fig. S5D (highlighted in red color). For 
irreversible reactions such as neddylation (𝑘10) and deneddylation (𝑘12) the net rate constant is 
identical with the rate constant. Then the net rate constant 𝑘6 is given by 
 
 
 
𝑘6 = 𝑘𝑜𝑛,11[𝐶𝑆𝑁]
𝑘12
𝑘12 + 𝑘𝑜𝑓𝑓,11
 (S15) 
where [𝐶𝑆𝑁] = 82𝑛𝑀  denotes the concentration of free (unbound) CSN under steady state 
conditions (with [S1]=0). The other 5 net rate constants are defined recursively as 
 
𝑘5 = 𝑘𝑜𝑓𝑓,6
𝑘10
𝑘10 + 𝑘𝑜𝑛,6[𝐶𝑎𝑛𝑑1]
 (S16) 
𝑘4 = 𝑘𝑜𝑛,2([𝐹𝑏1] + [𝐹𝑏2] + [𝐹𝑏2 • 𝑆2])
𝑘5
𝑘5 + 𝑘𝑜𝑓𝑓,2
 (S17) 
𝑘3 = 𝑘𝑜𝑛,9[𝐷𝐶𝑁1]
𝑘4
𝑘4 + 𝑘𝑜𝑓𝑓,9
 (S18) 
𝑘2 = 𝑘𝑜𝑓𝑓,2
𝑘3
𝑘3 + 𝑘𝑜𝑛,2[𝐹𝑏1]
 (S19) 
𝑘1 = 𝑘𝑜𝑛,4[𝐶𝑎𝑛𝑑1]
𝑘2
𝑘2 + 𝑘𝑜𝑓𝑓,4
. (S20) 
 
The concentrations for Cand1, Fb1 (β-TrCP), Fb2 (auxiliary SR), Fb2•S2 and DCN1 are steady 
state concentrations that were obtained by integrating the model equations using the parameter 
set for WT cells (Tables T2-T13, T15) without substrate for Fb1. Note that in Eq. (S14) the factor 
in front of the fraction represents the effective “on rate” for binding of any free Skp1•F-box 
protein to Cul1•Cand1•DCN1 while in Eq. (S16) we used the on rate for binding of a particular 
F-box protein (Fb1) to bind to Cul1•Cand1. Combining the expressions in Eq. (S15) – (S20) 
yields the estimate for the average cycle time 
 
𝑡𝑐𝑦𝑐𝑙𝑒 =
1
𝑘1
+
1
𝑘2
+
1
𝑘3
+
1
𝑘4
+
1
𝑘5
+
1
𝑘6
+
1
𝑘10
+
1
𝑘12
. (S21) 
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